| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4226 | Ppk1-in-8 | Novel PPK1 inhibitor, preventing UTI effectively through the disruption of the PPK1 function |
|
| DCC4227 | pppone | Potent and selective antagonist of melanocortin-4 receptor (MC4R) |
|
| DCC4228 | Ppq-581 | Novel anti-influenza agent, interrupting the crucial RNP trafficking, resulting in influenza replication inhibition, preventing virus-induced cytopathic effects |
|
| DCC4229 | Ppt (water-heme Modulator) | Novel Modulator of Water-Heme Interactions in Low-Spin P450 Complexes of CYP2C9d and CYP125A1 |
|
| DCC4230 | Ppxy Budding Inhibitor 4 | Novel inhibitor of budding of mVP40 and eVP40 VLPs, blocking mVP40-795 Nedd4 protein-protein interaction. |
|
| DCC4231 | Ppxy Budding Inhibitor 5 | Specific blocker of the MARV VP40 PPxY-host Nedd4 interaction and subsequent PPxY-dependent egress of MARV VP40 VLPs. |
|
| DCC4232 | Pqa-11 | Novel potent neuroprotectant, inhibiting glutamate-induced cell death, caspase-3 activation, and amyloid β1-42-induced cell death, also suppressing mitogen-activated protein kinase kinase 4 (MKK4) and c-jun N-terminal kinase (JNK) signaling activated by n |
|
| DCC4233 | Pqc-078 | Novel inhibitor of IMPDH enzyme |
|
| DCC4234 | Pqq-tme | Novel human double minute 2 (HDM2) inhibitor |
|
| DCC4235 | Pqsr Antagonist M64 | Quorum sensing modulator as a PqsR antagonist |
|
| DCC4236 | Pradigastat Featured | Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat has anti-obesity and anti-diabetic effects. |
|
| DCC4237 | Pravadoline Maleate | Inhibitor of prostaglandin (PG) synthesis |
|
| DCC4238 | Prazosin | Inverse agonist at alpha-1 adrenergic receptors |
|
| DCC4239 | Prexasertib Monolactate Monohydrate | Novel inhibitor of checkpoint kinase 1 (CHK1) |
|
| DCC4240 | Pridopidine Hydrochloride | Inducer of Functional Neurorestoration Via the Sigma-1 Receptor |
|
| DCC4241 | prmt3 Inhibitor 1 | Allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3) |
|
| DCC4242 | prmt3 Inhibitor 14u | Potent and selective inhibitor of protein arginine methyltransferase 3 (PRMT3) |
|
| DCC4243 | Prmt4-in-1 | Novel potent and selective inhibitor of PRMT4 (also known as CARM1) |
|
| DCC4244 | Prmt5-in-4b14 | Novel potent PRMT5 inhibitor, exhibiting potent anti-proliferative activity against a panel of leukemia and lymphoma cells |
|
| DCC4245 | Prmt5-in-c17 Featured | Novel potent, selective, and cell active protein arginine methyltransferase 5 (PRMT5) inhibitor |
|
| DCC4246 | Prmts Inhibitor A36 | Potent inhibitor of protein arginine methyltransferases (PRMTs) |
|
| DCC4247 | Prmts Inhibitor A9 | Potent inhibitor of protein arginine methyltransferases (PRMTs) |
|
| DCC4248 | Prn1008 | Novel, Reversible Covalent BTK Inhibitor for Rheumatoid Arthritis |
|
| DCC4249 | Prn1126 | Novel reversible covalent selective LMP7 inhibitor |
|
| DCC4250 | pr-nhp5g | Antagonist at the NR1/NR2A subtype but an agonist at the NR1/NR2D subtype |
|
| DCC4251 | Probimane | Potent inhibitor of tumor metastasis, inhibiting calmodulin, sialic acid, lipoperoxidation, fibrinogen, cell-movement and the cell-cycle arrest |
|
| DCC4252 | Procaspase-8 Inhibitor 63-r | Novel selective procaspase-8 (Pro-C8) Inhibitor covalently binding the zymogen, or inactive precursor (pro-form), of caspase-8, but not other caspases |
|
| DCC4253 | Pro-nbdhex | Prodrug of NBDHEX, selectively inhibiting glutathione transferase (GST P1-1) with better water solubility, and more potent anticancer activities |
|
| DCC4254 | Protac 14a | Novel potent cereblon degrader with DC50 of 200 nM, and 64% protein degradation, as quantified by western blot |
|
| DCC4256 | Protac Cp17 | Novel highly potent degrader against EGFRL858R/T790M and EGFRdel19, reaching the lowest DC 50 values among all reported EGFR-targeting PROTACs |
|
